[1] VOLTA U,BONAZZI C,BIANCHI F B,et al.IgA antibodies to dietary antigens in liver cirrhosis[J].International Journal of Clinical and Laboratory Research,1987,17(3):235-242.
[2] LEFEBVRE P,CARIOU B,LIEN F,et al.Role of bile acids and bile acid receptors in metabolic regulation[J].Physiological Reviews,2009,89(1):147-191.
[3] RUSSELL D W,SETCHELL K D R.Bile acid biosynthesis[M].Biochemistry,1992,31(20):4737-4749.
[4] VLAHCEVIC Z R,STRAVITZ R T,HEUMAN D M,et al.Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat[J].Gastroenterology,1997,113(6):1949-1957.
[5] DUANE W C,JAVITT N B.27-hydroxycholesterol:production rates in normal human subjects[J].Journal of Lipid Research,1999,40(7):1194-1199.
[6] TAKAHASHI S,FUKAMI T,MASUO Y,et al.Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans[J].Journal of Lipid Research,2016,57(12):2130-2137.
[7] KUIPERS F,BLOKS V W,GROEN A K.Beyond intestinal soap-bile acids in metabolic control[J].Nature Reviews Endocrinology,2014,10(8):488-498.
[8] 陈志维,黎玉翠,暴梅佳,等.柱前衍生化高效液相色谱法测定猪胆粉结合胆酸中甘氨酸和牛磺酸的含量[J].药物分析杂志,2010,30(2):288-290.
[9] 邓启华,姚颖,刘婷,等.猪胆汁中三种主要胆汁酸的提取分离[J].中国生化药物志,2012,33(4):405-407.
[10] LEE F Y,DE AGUIAR VALLIM T Q,CHONG H K,et al.Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity[J].Molecular Endocrinology,2010,24(8):1626-1636.
[11] DE VREE J M,JACQUEMIN E,STURM E,et al.Mutations in the
MDR3 gene cause progressive familial intrahepatic cholestasis[J].Proceedings of the National Academy of Sciences of the United States of America,1998,95(1):282-287.
[12] STRAUTNIEKS S S,BULL L N,KNISELY A S,et al.A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis[J].Nature Genetics,11998,20(3):233-238.
[13] KÖNIG J,NIES A T,CUI Y H,et al.Conjugate export pumps of the multidrug resistance protein (MRP) family:localization,substrate specificity,and MRP2-mediated drug resistance[J].Biochimica et Biophysica Acta:Biomembranes,1999,1461(2):377-394.
[14] RIDLON J M,HARRIS S C,BHOWMIK S,et al.Consequences of bile salt biotransformations by intestinal bacteria[J].Gut Microbes,2016,7(1):22-39.
[15] LI Y Y,JADHAV K,ZHANG Y Q.Bile acid receptors in non-alcoholic fatty liver disease[J].Biochemical Pharmacology,2013,86(11):1517-1524.
[16] 王朋,林森,吴德,等.胆汁酸的营养生理作用及代谢调控研究进展[J].动物营养学报,2019,32(5):2002-2011.
[17] CHIANG J Y L.Regulation of bile acid synthesis:pathways,nuclear receptors,and mechanisms[J].Journal of Hepatology,2004,40(3):539-551.
[18] DOWLING R H.The enterohepatic circulation of bile acids as they relate to lipid disorders[J].Journal of Clinical Pathology,1973,5:59-67.
[19] RIDLON J M,KANG D J,HYLEMON P B.Bile salt biotransformations by human intestinal bacteria[J].Journal of Lipid Research,2006,47(2):241-259.
[20] STEINER C,HOLLEBOOM A G,KARUNA R,et al.Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids:effects of monogenic disturbances in high-density lipoprotein metabolism[J].Clinical Science,2012,122(8):385-400.
[21] MONTE M J,MARIN J J,ANTELO A,et al.Bile acids:chemistry,physiology,and pathophysiology[J].World Journal of Gastroenterology,2009,15(7):804-816.
[22] VITEK L,HALUZIK M.The role of bile acids in metabolic regulation[J].The Journal of Endocrinology,2016,228(3):R85-R96.
[23] SCHMID A,SCHLEGEL J,THOMALLA M,et al.Evidence of functional bile acid signaling pathways in adipocytes[J].Molecular and Cellular Endocrinology,2019,483:1-10.
[24] KADIR S H S A,MIRAGOLI M,ABU-HAYYEH S,et al.Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes[J].PLoS One,2010,5(3):e9689.
[25] ABDELKARIM M,CARON S,DUHEM C,et al.The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-γ and interfering with the Wnt/β-catenin pathways[J].Journal of Biological Chemistry,2010,285(47):36759-36767.
[26] CARIOU B,VAN HARMELEN K,DURAN-SANDOVAL D,et al.The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice[J].Journal of Biological Chemistry,2006,281(16):11039-11049.
[27] GOODWIN B,JONES S A,PRICE R R,et al.A regulatory cascade of the nuclear receptors FXR,SHP-1,and LRH-1 represses bile acid biosynthesis[J].Molecular Cell,2000,6(3):517-526.
[28] INAGAKI T,CHOI M,MOSCHETTA A,et al.Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis[J].Cell Metabolism,2005,2(4):217-225.
[29] SINAL C J,TOHKIN M,MIYATA M,et al.Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis[J].Cell,2000,102(6):731-744.
[30] PIRCHERP C,KITTO J L,PETROWSKI M L,et al.Farnesoid X receptor regulates bile acid-amino acid conjugation[J].Journal of Biological Chemistry,2003,278(30):27703-27711.
[31] LU T T,MAKISHIMA M,REPA J J,et al.Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors[J].Molecular Cell,2000,6(3):507-515.
[32] ZHANG M,CHIANG J Y L.Transcriptional regulation of the human sterol 12α-hydroxylase gene (
CYP8B1):roles of hepatocyte nuclear factor 4α in mediating bile acid repression[J].Journal of Biological Chemistry,2001,276(45):41690-41699.
[33] CHEN F,MA L,DAWSON P A,et al.Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter[J].Journal of Biological Chemistry,2003,278(22):19909-19916.
[34] GROBER J,ZAGHINI I,FUJⅡ H,et al.Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene.Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer[J].Journal of Biological Chemistry,1999,274(42):29749-29754.
[35] LANDRIER J F,ELORANTA J J,VAVRICKA S R,et al.The nuclear receptor for bile acids,FXR,transactivates human organic solute transporter-α and-β genes[J].American Journal of Physiology:Gastrointestinal and Liver Physiology,2006,290(3):G476-G485.
[36] YU C D,WANG F,KAN M,et al.Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4[J].Journal of Biological Chemistry,2000,275(20):15482-15489.
[37] WANG L L,WU G X,WU F H,et al.Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats[J].Journal of Ethnopharmacology,2017,196:178-185.
[38] 辛瑜,杨暄,奚涛,等.孕烷X受体:肝脏疾病的潜在药物靶标[J].药学进展,2018,42(12):922-928.
[39] KEITEL V,CUPISTI K,ULLMER C,et al.The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders[J].Hepatology,2009,50(3):861-870.
[40] WATANABE M,HOUTEN S M,MATAKI C,et al.Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation[J].Nature,2006,439(7075):484-489.
[41] KEITEL V,ULLMER C,HÄUSSINGER D.The membrane-bound bile acid receptor TGR5(GPBAR-1) is localized in the primary cilium of cholangiocytes[J].Biological Chemistry,2010,391(7):785-789.
[42] FOORD S M,BONNER T I,NEUBIG R R,et al.International Union of Pharmacology.XLVI.G protein-coupled receptor list[J].Pharmacological Reviews,2005,57(2):279-288.
[43] KAWAMATA Y,FUJⅡ R,HOSOYA M,et al.A G protein-coupled receptor responsive to bile acids[J].Journal of Biological Chemistry,2003,278(11):9435-9440.
[44] WATANABE M,HOUTEN SM,WANG L,et al.Bile acids lower triglyceride levels via a pathway involving FXR,SHP,and SREBP-1c[J].Journal of Clinical Investigation,2004,113(10):1408-1418.
[45] BHATNAGAR S,DAMRON H A,HILLGARTNER F B.Fibroblast growth factor-19,a novel factor that inhibits hepatic fatty acid synthesis[J].Journal of Biological Chemistry,2009,284(15):10023-10033.
[46] RAO A,KOSTERS A,MELLS J E,et al.Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice[J].Science Translational Medicine,2016,8(357):357ra122.
[47] HIROKANE H,NAKAHARA M,TACHIBANA S,et al.Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4[J].Journal of Biological Chemistry,2004,279(44):45685-45692.
[48] KAST H R,NGUYEN C M,SINAL C J,et al.Farnesoid X-activated receptor induces apolipoprotein C-Ⅱ transcription:a molecular mechanism linking plasma triglyceride levels to bile acids[J].Molecular Endocrinology,2001,15(10):1720-1728.
[49] CLAUDEL T,INOUE Y,BARBIER O,et al.Farnesoid X receptor agonists suppress hepatic apolipoprotein CⅢ expression[J].Gastroenterology,2003,125(2):544-555.
[50] SIRVENT A,CLAUDEL T,MARTIN G,et al.The farnesoid X receptor induces very low density lipoprotein receptor gene expression[J].FEBS Letters,2004,566(1/2/3):173-177.
[51] CLAUDEL T,STURM E,DUEZ H,et al.Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element[J].Journal of Clinical Investigation,2002,109(7):961-971.
[52] ZHANG Y Q,YIN L Y,ANDERSON J,et al.Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia[J].Journal of Biological Chemistry,2010,285(5):3035-3043.
[53] GAUTIER T,DE HAAN W,GROBER J,et al.Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice[J].Journal of Lipid Research,2013,54(8):2195-2205.
[54] D'AGATI V D,CHAGNAC A,DE VRIES A P J,et al.Obesity-related glomerulopathy:clinical and pathologic characteristics and pathogenesis[J].Nature Reviews Nephrology,2016,12(8):453-471.
[55] PREIDIS G A,KIM K H,MOORE D D.Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance[J].Journal of Clinical Investigation,2017,127(4):1193-1201.
[56] ALVAREZ-SOLA G,URIARTE I,LATASA M U,et al.Fibroblast growth factor 15/19(FGF15/19) protects from diet-induced hepatic steatosis:development of an FGF19-based chimeric molecule to promote fatty liver regeneration[J].Gut,2017,66(10):1818-1828.
[57] PICARD A,SOYER J,BERNEY X,et al.A genetic screen identifies hypothalamic FGF15 as a regulator of glucagon secretion[J].Cell Reports,2016,17(7):1795-1806.
[58] VAN DIJK T H,GREFHORST A,OOSTERVEER M H,et al.An increased flux through the glucose 6-phosphate pool in enterocytes delays glucose absorption in
Fxr-/- mice[J].Journal of Biological Chemistry,2009,284(16):10315-10323.
[59] DURAN-SANDOVAL D,CARIOU B,PERCEVAULT F,et al.The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition[J].Journal of Biological Chemistry,2005,280(33):29971-29979.
[60] CARON S,HUAMAN SAMANEZ C,DEHONDT H,et al.Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes[J].Molecular and Cellular Biology,2013,33(11):2202-2211.
[61] KIR S,BEDDOW S A,SAMUEL V T,et al.FGF19 as a postprandial,insulin-independent activator of hepatic protein and glycogen synthesis[J].Science,2011,331(6024):1621-1624.
[62] KATSUMA S,HIRASAWA A,TSUJIMOTO G.Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1[J].Biochemical and Biophysical Research Communications,2005,329(1):386-390.
[63] THOMAS C,GIOIELLO A,NORIEGA L,et al.TGR5-mediated bile acid sensing controls glucose homeostasis[J].Cell Metabolism,2009,10(3):167-177.
[64] BRIGHTON C A,RIEVAJ J,KUHRE R E,et al.Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors[J].Endocrinology,2015,156(11):3961-3970.
[65] TRABELSI M S,DAOUDI M,PRAWITT J,et al.Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells[J].Nature Communications,2015,6:7629.
[66] KAUR A,PATANKAR J V,DE HAAN W,et al.Loss of
Cyp8b1 improves glucose homeostasis by increasing GLP-1[J].Diabetes,2015,64(4):1168-1179.
[67] POPESCU I R,HELLEBOID-CHAPMAN A,LUCAS A,et al.The nuclear receptor FXR is expressed in pancreatic β-cells and protects human islets from lipotoxicity[J].FEBS Letters,2010,584(13):2845-2851.
[68] KUMAR D P,ASGHARPOUR A,MIRSHAHI F,et al.Activation of transmembrane bile acid receptor TGR5 modulates pancreatic islet α cells to promote glucose homeostasis[J].Journal of Biological Chemistry,2016,291(13):6626-6640.
[69] POTTHOFF M J,BONEY-MONTOYA J,CHOI M,et al.FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway[J].Cell Metabolism,2011,13(6):729-738.
[70] JONES H,ALPINI G,FRANCIS H.Bile acid signaling and biliary functions[J].Acta Pharmaceutica Sinica B,2015,5(2):123-128.
[71] KWONG E,LI Y Z,HYLEMON P B,et al.Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism[J].Acta Pharmaceutica Sinica B,2015,5(2):151-157.
[72] STUDER E,ZHOU X Q,ZHAO R P,et al.Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes[J].Hepatology,2012,55(1):267-276.
[73] STRUB G M,MACEYKA M,HAIT N C,et al.Extracellular and intracellular actions of sphingosine-1-phosphate[J].Oxygen Transport to Tissue ⅩⅩⅩⅢ,2010,688:141-155.
[74] MIAO J,XIAO Z,KANAMALURU D,et al.Bile acid signaling pathways increase stability of small heterodimer partner (SHP) by inhibiting ubiquitin-proteasomal degradation[J].Genes & Development,2009,23(8):986-996.
